Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04070599

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

Conditions: Immune Thrombocytopenic Purpura, Autoimmune Thrombocytopenia, Thrombopenia

Sex: All

Ages: 2 Years – N/A

Healthy volunteers: No

Phase: PHASE3

Enrollment: 70

Sponsor: University Hospital, Bordeaux

Location: CHU de Bordeaux Bordeaux

Summary

This study aims to determine the hemato-immunological parameters predictive of the evolution of a Immune thrombocytopenic purpura (ITP) towards chronicity, and to identify possible differences between the child and the adult.

Eligibility Criteria

Inclusion Criteria: * Minor patients aged 2 to 18 recruited at the Children's Hospital, in the service of Prof. Y. PEREL, Dr. N. ALADJIDI, CEREVANCE, * Adult patients (\> 18 years old) recruited at the Haut-Lévêque hospital, Pr JL PELLEGRIN, Pr JF VIALLARD, GECAI, * Patient with acute Immune thrombocytopenic purpura, seen at initial diagnosis or within 8 days (defined as thrombocytopenia \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04070599). StuddyBuddy aggregates publicly available trial information.